Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
71 InagiR.KumagaiT.FujitaT.NangakuM
Mol Metab 4: 718-731, 2015
The full scope at Ascend includes: Obesity and overweight with comorbidities - full workup, GLP-1 candidacy assessment, lifestyle integration Type 2 diabetes with weight management goals - GLP-1 medications often address both indications simultaneously Hypertension tied to weight - coordinated medication review and lifestyle work Dyslipidemia and metabolic syndrome - lipids often improve markedly with weight loss Prediabetes - HbA1c 5.7-6.4% range, where intervention can prevent progression Fatty liver disease (MASLD) - weight loss is the primary intervention
Her passion for helping people led her to attend medical school in Cambridge, UK
US$ 24.26
US$ 21.52
US$ 20.58
US$ 23.24
US$ 22.88
US$ 25.95
US$ 28.72
US$ 26.66
US$ 26.45
US$ 23.54
US$ 23.01
US$ 24.26
